Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03775850
Title A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Evelo Biosciences, Inc.

Advanced Solid Tumor

urinary bladder cancer

colorectal cancer

lung non-small cell carcinoma

gastroesophageal cancer

triple-receptor negative breast cancer

renal cell carcinoma



EDP1503 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.